Erectile dysfunction: Cardiovascular risk and the role of the cardiologist

International Journal of Clinical Practice

Volumn 57, Issue 2, 2003, Pages 96-99

  Solomon, H ^a   Man, J ^a   Wierzbicki, A S ^a   O'Brien, T ^b   Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LIPID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; STRATIFICATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIOLOGY SERVICE, HOSPITAL; CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; HUMANS; HYPERTENSION; IMPOTENCE, VASCULOGENIC; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHYSICIAN'S ROLE; RISK ASSESSMENT; RISK FACTORS;

EID: 0037347857     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br J Urol 1999; 84: 50-56.
2. Harling R. National guidance is needed is needed for Viagra. BMJ 2001; 317: 165.
3. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20(6): 323-334.
4. Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. Br J Urol Int 2001; 87(9): 838-845.
5. Feldman HA, McKinlay JB, Goldstein I. Erectile dysfunction, cardiovascular disease and cardiovascular risk factors: prospective results in a large random sample of Massachusetts men. J Urol 1998; 159(suppl 5): 91.
6. Kloner RA. Cardiovascular risk and sildenafil. Am J Cardiol 2000; 86(2A): 57F-61F.
7. Chew KK, Stuckey BG, Thompson PL. Erectile dysfunction, sildenafil and cardiovascular risk. Med J Aust 2000; 172(6): 279-283.
8. Cheitlin MD, Hutter AM, Jr, Brindis RG et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation 1999; 99(1): 168-177.
9. Kostis JB, Padma-Nathan H, Rosen RC. A symposium: sexual activity and cardiac risk: the Princeton Conference. Am J Cardiol 2000; 86(2A): 1F-68F.
10. DeBusk R, Drory Y, Goldstein I et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86(2): 175-181.
11. Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6): 822-830.
12. Jackson G, Betteridge J, Dean J et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract 1999; 53(6): 445-451.
13. Fedder DO, Koro CE, L'Italien GJ. New national cholesterol education program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation 2002; 105(2): 152-156.
14. Anderson M, Nicholson B, Louie E, Mulhall JP. An analysis of vasculogenic erectile dysfunction as a potential predictor of occult cardiac disease. J Urol 1998; 159(suppl 5): 118.
15. Pritzker M. The penile stress test: a window to the hearts of man? Circulation 1999; 100(18): 3751.